Annotation Detail for PLEKHO2

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04060 | Cytokine-cytokine receptor interaction |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of PLEKHO2 mRNA | increases expression | 17426115
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of PLEKHO2 mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.72 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.37 | 16434500 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.70 | 19483382 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.69 | 16050911 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.19 | 19176532 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
1.93 | 19769572 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.61 | 18249437 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
5.77 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
3.02 | 12083418 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.31 | 19236843 20131406 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
3.20 | 16080930 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.81 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.76 | 16221962 18467677 19772884 19176532 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.83 | 16490937 16863852 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
5.04 | 14716179 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.69 | 20558911 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
5.28 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.93 | 16306350 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
3.05 | 12488133 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.49 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
2.49 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.95 | 16377806 20007298 15890375 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.48 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
1.90 | 11062179 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.27 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.30 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.33 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.14 | 17405874 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.90 | 20558911 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.23 | 15084515 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.58 | 19058328 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.53 | 18709164 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.93 | 16517955 |
Pathway ID |
Pathway Name |
---|
KEGG:04060 |
Cytokine-cytokine receptor interaction |